SM
Sirgo Mark A Director
Board M
US US · SEC (Form 4)
€695,016
▲ Purchases (18 ops.)
Explore the detailed record of transactions filed by Sirgo Mark A, Director. Director active across 2 companies, notably Biodelivery Sciences International INC. In total, 27 filings have been logged. Total volume traded: €749k. The latest transaction was disclosed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 27 total
€47,743 106,383 shares @ €0.4488 11.2% of flow
Common Stock
SEC:0001578563-22-000016:0 · 18 May 2022
Ideal exit: 12 Feb 2023 (T+270) 01,166,866 shares 0
Common Stock
SEC:0001103021-22-000071:0 · 22 Mar 2022
€44,997 86,449.55 shares @ €0.5205 10.6% of flow
Common stock
SEC:0001551986-22-000023:0 · 3 Mar 2022
Ideal exit: 28 Nov 2022 (T+270) 07,684 shares 0
Common Stock
SEC:0001103021-22-000023 · 27 Jan 2022
07,684 shares 0
Common Stock
SEC:0001103021-22-000023:0 · 27 Jan 2022
€44,171 18,587 shares @ €2.3764 27.3% of flow
Common Stock
SEC:0001103021-21-000124 · 2 Dec 2021
Ideal exit: 29 Aug 2022 (T+270) €44,171 18,587 shares @ €2.3764 13.6% of flow
Common Stock
SEC:0001103021-21-000124:0 · 2 Dec 2021
Ideal exit: 29 Aug 2022 (T+270) €39,313 50,000 shares @ €0.7863 23.7% of flow
Common Stock
SEC:0001578563-21-000044 · 2 Dec 2021
Ideal exit: 29 Aug 2022 (T+270) €39,313 50,000 shares @ €0.7863 9.3% of flow
Common Stock
SEC:0001578563-21-000044:0 · 2 Dec 2021
Ideal exit: 29 Aug 2022 (T+270) €18,726 20,000 shares @ €0.9363 11.3% of flow
Common stock
SEC:0001551986-21-000122 · 18 Nov 2021
Ideal exit: 15 Aug 2022 (T+270) €18,726 20,000 shares @ €0.9363 4.4% of flow
Common stock
SEC:0001551986-21-000122:0 · 18 Nov 2021
Ideal exit: 15 Aug 2022 (T+270) €26,852 10,000 shares @ €2.6852 16.6% of flow
Common Stock
SEC:0001103021-21-000116 · 18 Nov 2021
€26,852 10,000 shares @ €2.6852 16.6% of flow
Common Stock
SEC:0001103021-21-000118 · 18 Nov 2021
Ideal exit: 15 Aug 2022 (T+270) €26,852 10,000 shares @ €2.6852 8.3% of flow
Common Stock
SEC:0001103021-21-000116:0 · 18 Nov 2021
€26,852 10,000 shares @ €2.6852 8.3% of flow
Common Stock
SEC:0001103021-21-000118:0 · 18 Nov 2021
Ideal exit: 15 Aug 2022 (T+270) €44,576 16,000 shares @ €2.786 27.5% of flow
Common Stock
SEC:0001103021-21-000112 · 11 Nov 2021
Ideal exit: 8 Aug 2022 (T+270) €44,576 16,000 shares @ €2.786 13.8% of flow
Common Stock
SEC:0001103021-21-000112:0 · 11 Nov 2021
Ideal exit: 8 Aug 2022 (T+270) €84,434 73,529 shares @ €1.1483 50.9% of flow
Common stock
SEC:0001551986-21-000101 · 7 Sept 2021
Ideal exit: 4 Jun 2022 (T+270) €84,434 73,529 shares @ €1.1483 19.9% of flow
Common stock
SEC:0001551986-21-000101:0 · 7 Sept 2021
Ideal exit: 4 Jun 2022 (T+270) 04,000 shares 0
Common Stock
SEC:0001103021-21-000082 · 23 Aug 2021
04,000 shares 0
Common Stock
SEC:0001103021-21-000082:0 · 23 Aug 2021
€23,551 25,000 shares @ €0.9421 14.2% of flow
Common stock
SEC:0001551986-21-000097 · 20 Aug 2021
Ideal exit: 17 May 2022 (T+270) €23,551 25,000 shares @ €0.9421 5.5% of flow
Common stock
SEC:0001551986-21-000097:0 · 20 Aug 2021
Ideal exit: 17 May 2022 (T+270) 04,000 shares 0
Common Stock
SEC:0001103021-21-000078 · 6 Aug 2021
04,000 shares 0
Common Stock
SEC:0001103021-21-000078:0 · 6 Aug 2021
25 of 27 declarations
Load more (2 remaining) About Sirgo Mark A Mark A Sirgo is an executive at BIODELIVERY SCIENCES INTERNATIONAL INC.